BioOutsource and Cellca offer a unique approach to help advance our clients’ drug candidates from preclinical development through to commercialisation .
Benefit from the combined experience of Cellca, BioOutsource and Sartorius Stedim Biotech to efficiently advance your drug candidates quickly from early stage development through to commercialisation. Our extensive suite of services combines Cellca’s cell line and upstream process development expertise with BioOutsource’s bioanalytical and biosafety contract testing services to support customers from cell line development, through product manufacture and release.
Speed to clinic
Offering robust platforms, off-the shelf assays and a commitment to providing a total solution, Sartorius Stedim Biotech can accelerate your drug development. Our model is effective in reducing client’s timelines with our unique technology platform for cell line development and our readily available assays to assess the quality and safety of drugs throughout development.
Working closely with our clients enables us to foresee industry trends, challenges and opportunities. Our R&D teams work on developing innovative solutions tailored to market needs. In particular BioOutsource and Cellca are industry leading experts in supporting biosimilar drug development, our combined experience and innovative methods advance projects through the development pathway. As well as our highly experienced team of quality auditors and specialists, who have a wealth of knowledge on regulatory requirements for testing biosimilars, biologics and vaccines and have excellent regulatory insight for generating data required for submissions.
Our clients come first and we make every effort to deliver service excellence in everything we do. Working with a dedicated client manager our clients experience a streamlined process which ensures effective communication through the life cycle of their project. We believe that communication is key to success, and our team take a proactive approach to ensure the delivery of a truly differentiated solution.